baber/WOPTO huggingface dataset:
Patent CA-3176981-A1 (CA)
Inventor: CRONIN LEROY
IPC: G16C20/10
Filed: 2021-04-28
Abstract: L'invention concerne un procédé de commande d'une plateforme de chimie automatisée mettant en oeuvre des procédures synthétiques écrites en langage naturel. Le procédé utilise des techniques de traitement automatique du langage naturel (NLP) pour interpréter une procédure de synthèse écrite en langage scientifique naturel et extraire un ensemble d'instructions lisibles par machine comprenant les opérations distinctes nécessaires à la réalisation de la synthèse sur une plateforme de synthèse chimique automatisée. Le procédé comprend également l'étape consistant à exécuter l'ensemble d'instructions lisibles par machine sur une plate-forme de synthèse chimique automatisée.
Patent CA-3177884-A1 (CA)
Title: Systemes d'immersion et procedes de pre-lavage ou de lavage d'argenterie
Inventor: CANTRELL JOHN
IPC: A47L15/24
Filed: 2021-07-07
Abstract: L'invention concerne un système de pré-lavage et de lavage d'argenterie constitué d'un bassin unitaire avec un à cinq, et de préférence trois, paniers poreux verticalement mobiles disposés radialement autour d'un mécanisme de levage et d'abaissement vertical central. La base avec un bassin unitaire contient une quantité d'un ou de plusieurs fluides de lavage dans lesquels chacun des paniers poreux verticalement mobiles peut être immergé de manière répétée. Le couvercle de base définit des orifices cylindriques à travers lesquels les paniers sont soulevés et abaissés. Les paniers poreux comprennent des réseaux de perforations pour permettre au fluide de lavage de s'écouler dans des trajets non linéaires à travers l'argenterie contenue dans le panier, ce qui permet de laver tous les côtés de l'argenterie et de réagencer de manière avantageuse l'argenterie dans le panier au fur et à mesure que le processus de lavage se déroule.
Patent CA-3178115-A1 (CA)
Title: Sars-cov-2 vaccines
Inventor: YELENSKY ROMAN
IPC: A61K35/15
Filed: 2021-05-19
Abstract: Disclosed herein are vaccine compositions that include SARS-CoV-2 MHC epitope-encoding cassettes and/or full-length SARS-CoV-2 proteins. Also disclosed are nucleotides, cells, and methods associated with the compositions including their use as vaccines.
Patent CA-3179320-A1 (CA)
Title: Crystalline forms of a cd73 inhibitor and uses thereof
Inventor: PENNELL ANDREW M K
IPC: C07H19/14
Filed: 2021-06-16
Abstract: Crystalline forms of the compound of Formula (I), which modulates the conversion of AMP to adenosine by 5'-nucleotidase, and compositions containing the compound and methods for preparing the crystalline forms, are described herein. The use of such crystalline form of Formula (I) and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer and immune-related disorders, that are mediated by 5'-nucleotidase is also provided.
Patent CA-3179911-A1 (CA)
Inventor: EDAVETTAL SUZANNE
IPC: A61K47/68
Filed: 2021-04-07
Abstract: L'invention concerne des anticorps monoclonaux anti-TfR et des fragments de liaison à l'antigène de ceux-ci pour administrer un agent au cerveau d'un sujet en ayant besoin. L'invention concerne également des conjugués et des constructions de fusion contenant l'anticorps anti-TfR ou un fragment de liaison à l'antigène de celui-ci couplé à un agent thérapeutique ou diagnostique, tel qu'un second anticorps et un second fragment de liaison à l'antigène de celui-ci, pour traiter ou détecter un trouble neurologique et/ou administrer un agent thérapeutique ou diagnostique à travers la barrière hémato-encéphalique. L'invention concerne également des acides nucléiques codant pour les anticorps, des conjugués et des constructions de fusion et des cellules hôtes recombinantes associées.
Patent CA-3180003-A1 (CA)
Title: Composition de traitement et procede de reduction de la viscosite d'hydrocarbures
Inventor: TALLEY CHARLES BULLICK
IPC: F17D1/00
Filed: 2021-02-05
Abstract: L'invention concerne une composition de traitement destinée à réduire la viscosité, le point d'écoulement et la teneur en précipité d'un fluide hydrocarboné à des températures inférieures à 90 °F, de préférence de 34 °F à 90 °F. La composition de traitement comprend un ou plusieurs esters méthyliques d'acides gras mélangés, un mélange aromatique constitué essentiellement de composés aromatiques en C9 à C15 et un solvant principal constitué essentiellement de kérosène à faible odeur, de diesel à faible odeur ou d'un mélange de diesel à faible odeur ou de kérosène à faible odeur. La composition de traitement solubilise les dépôts hydrocarbonés pour les éliminer. La composition de traitement solubilise également les paraffines et les asphaltènes dans un fluide hydrocarboné pour prévenir ou atténuer la formation de dépôts hydrocarbonés.
Patent CA-3183724-A1 (CA)
Inventor: JOHNS CLIFFORD L
IPC: F28G1/16
Filed: 2021-04-05
Abstract: A grit blasting arrangement for cleaning chemical reactor tubes includes means for ensuring the grit blast nozzle is coaxial with the longitudinal axis of the tube to be cleaned.
Patent CA-3185378-A1 (CA)
Title: Hemostatic material composition
Inventor: KURAMOTO MAMORU
IPC: A61L24/04
Filed: 2022-12-16
Abstract: The hemostatic material composition contains a polysaccharide having a reactive group that reacts with a protein to form a crosslinking structure and contains a hydrophobic solvent.
Patent CA-3188412-A1 (CA)
Title: Inht30 transgenic soybean
Inventor: NUCCIO MICHAEL LEE
IPC: C12N15/82
Filed: 2021-07-30
Abstract: Transgenic INHT30 soybean plants comprising modifications of the MON87708 soybean locus which provide for facile excision of the modified MON87708 transgenic locus or portions thereof, methods of making such plants, and use of such plants to facilitate breeding are disclosed.
Patent CA-3191052-A1 (CA)
Inventor: TELGMANN STEFFEN
IPC: G06Q50/02
Filed: 2021-08-27
Abstract: L'invention concerne un dispositif de pulvérisation (20) ayant plus d'une buse de pulvérisation (28) pour traiter une zone agricole (11), au moins deux buses de pulvérisation (28) étant reliées de façon fluidique par l'intermédiaire d'une ligne fluidique commune (26), le dispositif de pulvérisation (20) comprenant : - un système de commande (32) conçu pour commander l'activation de la ou des buses de pulvérisation individuelle(s) sur la base d'un signal d'activation, - un capteur (34) conçu pour mesurer une propriété de fluide dans la ligne fluidique commune (26), - une unité de surveillance conçue pour surveiller des buses de pulvérisation (28) sur la base de la propriété de fluide mesurée et du signal d'activation.
Patent CA-3192385-A1 (CA)
Title: Clinical dosing of sirp1a chimeric protein
Inventor: PANDITE ARUNDATHY
IPC: A61P35/00
Filed: 2021-09-17
Abstract: The present disclosure relates, inter alia, to methods of treating cancer with chimeric proteins comprising an extracellular domain of human signal regulatory protein a (CD172a (SIRP?)) and an extracellular domain of human CD40 ligand (CD40L), including doses and regimens.
Patent CA-3193897-A1 (CA)
Inventor: SCHIPA MAURIZIO
IPC: G06Q30/06
Filed: 2021-09-28
Abstract: A method for remotely purchasing non-fungible products with home delivery comprises the step of providing an image acquisition system at a point of sale. The method further comprises the step of supplying to a remote user via the acquisition system the images in real time of a plurality of non-fungible products which are present at the point of sale, and the step of acquiring at the point of sale an indication of selection by the remote user, which is associated with at least one non-fungible product included in the plurality of non-fungible products which are present in the images supplied to the remote user. The method further includes the step of uniquely and non-detachably labelling the at least one non-fungible product selected by uniquely identifying it in real time after confirmation by the remote user, and the step of packing the at least one non-fungible product which has been uniquely labelled in a sealed packaging for delivery of the product to the home of the remote user without any changes of identity and uniqueness. An image acquisition apparatus may be integrated in a product display counter and may be connected to a processing node which interacts with a remote terminal for uniquely selecting a non-fungible product.
Patent CA-3196014-A1 (CA)
Title: Specificity enchanced bispecific antibody (seba)
Inventor: GOULET DENNIS R
IPC: A61K39/395
Filed: 2021-09-21
Abstract: A bispecific tetravalent antibody having a binding specificity to a human epithelium growth factor receptor (EGFR), comprising, from N terminus to C terminus, a Fab region having a first binding specificity to human EGFR, wherein the Fab region comprises a variable region having an amino acid sequence having at least 90% of sequence identity to the sequences as disclosed herein; a Fc domain, and a scFv domain having a second binding specificity to HER3.
Patent CA-3196949-A1 (CA)
Title: Encoding and decoding immersive video
Inventor: VAN GEEST BARTOLOMEUS WILHELMUS DAMIANUS
IPC: H04N19/597
Filed: 2021-09-23
Abstract: Concepts for encoding and decoding multi-view data for immersive video are disclosed. In an encoding method, metadata is generated comprising a field indicating if a patch data unit of the multi-view data comprises in-painted data for representing missing data. The generated metadata provides a means of distinguishing patch data units comprising original texture and depth data from patch data units comprising in-painted data (e.g. in-painted texture and depth data). The provision of such information within the metadata of immersive video may address problems associated with blending and pruned view reconstruction. Also provided are an encoder and a decoder for multi-view data for immersive video, and a corresponding bitstream, comprising metadata.
Patent CA-3198526-A1 (CA)
Title: Chemical modifications for inhibiting expression of aldh2
Inventor: BROWN BOB DALE
IPC: C12N9/02
Filed: 2021-11-12
Abstract: This disclosure relates to chemically modified oligonucleotides, compositions, and methods useful for reducing ALDH2 expression, to treat alcoholism. Disclosed oligonucleotide for the reduction of ALDH2 expression is modified for enhanced pharmacological properties.
Patent CA-3199624-A1 (CA)
Title: Information processing system
Inventor: SUETOMI RYO
IPC: G06F3/04842
Filed: 2021-10-01
Abstract: An information processing system includes: a motion data acquisition unit that acquires motion data, in a real environment, of a user who is operating an avatar in a virtual reality space; and an attribute estimation unit that estimates an attribute of the user on a basis of the acquired motion data.
Patent CA-3201609-A1 (CA)
Title: Lateral locating assembly for lateral intervention
Inventor: RODRIGUEZ FRANKLIN CHARLES
IPC: E21B7/06
Filed: 2021-02-12
Abstract: Provided, in one aspect, is a lateral locating assembly. The lateral locating assembly may include, in one aspect, a housing, as well as a piston positioned within the housing. The lateral locating assembly according to this aspect may further include a mandrel extending from a distal end of the housing, the mandrel configured to rotate and translate angularly in response to the piston moving from a first position to a second position, and a deflection tip coupled with a distal end of the mandrel, the deflection tip configured to rotate and angularly translate with the mandrel relative to the housing.
Patent CA-3201752-A1 (CA)
Title: Use of synthetic peptide for the induction of antitumor and antiviral immunty
Inventor: AGUILAR NORIEGA DAYLEN
IPC: A61P35/00
Filed: 2021-11-23
Abstract: Use of the peptide identified as SEQ ID NO: 1 for manufacturing a drug which induces antitumor and antiviral immunity mediated by immunogenic cell death. The invention also provides a method for treating cancer or viral infections, characterised in that it administers, to an individual in need, a therapeutically effective amount of a drug for the induction of antitumor and antiviral immunity mediated by immunogenic cell death, the drug comprising said synthetic peptide. The invention also relates to a pharmaceutical combination comprising the peptide identified as SEQ ID NO: 1 and a vaccine for cancer immunotherapy, which results in a more effetive immunotherapeutic approach to this disease.
Patent CA-3202013-A1 (CA)
Title: Hydrocarbon recovery unit with recycle loop for adsorbent bed regeneration
Inventor: DOLAN WILLIAM B
IPC: C07C7/12
Filed: 2021-12-12
Abstract: Disclosed in certain embodiments are processes for heavy hydrocarbon removal that implement a regeneration loop that introduces an absorbent into a regeneration gas stream, and systems for implementing the same.
Patent CA-3204051-A1 (CA)
Inventor: LIAN BRIAN
IPC: C07F9/38
Filed: 2022-01-18
Abstract: Disclosed herein are small molecule GIP/GLP-1 dual receptor agonist compositions, pharmaceutical compositions, the use and preparation thereof.
Patent CA-3204432-A1 (CA)
Inventor: DOLL MICHAEL
IPC: C25B1/04
Filed: 2022-02-17
Abstract: The invention relates to a method of operating an electrolyzer of the cell-stack type, wherein the respective cell voltage of at least two different cells of the cell-stack is measured, wherein said at least two cells are fixedly wired such as to allow automated measuring and that measuring signals from the wiring allocated for measurement of at least two different cells are, by an in particular automatic switching, channelled time-shifted with respect to each other via a common wiring path segment.
Patent CA-3205633-A1 (CA)
Title: Procede
Inventor: BARD FREDERIC
IPC: A61P19/02
Filed: 2022-01-21
Abstract: L'invention concerne des procédés et des traitements pour la dégradation du cartilage, le procédé comprenant l'administration d'un agent thérapeutique qui inhibe la voie d'activation de GalNAc-T (GALA).
Patent CA-3205705-A1 (CA)
Title: Authentication for a network service
Inventor: KARAMPATSIS DIMITRIOS
IPC: H04L9/40
Filed: 2022-02-18
Abstract: Apparatuses, methods, and systems are disclosed for authentication for a network service. One method (800) includes receiving (802), at a first network device from a second network device, a network function service request to execute a service on a third network device. The request includes first credentials for authentication with a first network device and second credentials for authentication with the third network device. The method (800) includes determining (804) whether the first credentials provided are valid and execute the service request by determining the third network device to execute the service requested from the second network device. The method (800) includes transmitting (806), to a fourth network device, a request for authentication with the third network device. The request includes an identifier of the third network device and second credentials of the second network device.
Patent CA-3207405-A1 (CA)
Title: Method for providing a clinical decision support, corresponding system for providing a clinical decision support, and computer program product
Inventor: MANGANARO LORENZO
IPC: G16H50/30
Filed: 2023-07-24
Abstract: Described herein are solutions for providing a support to clinical decisions using a trained nonlinear classifier. For this purpose, a computer obtains (1202) for a patient (P) respective values (300) of a plurality of clinical data (p). Next, the computer generates a training dataset (306). For this purpose, the computer estimates (1204), by means of the nonlinear classifier, a respective class of risk (v) for the values of the patient (P) and adds the values of the patient (P) and the respective estimated class of risk (v) to the training dataset (306). The computer moreover generates (1406) a plurality of modified datasets (304) by modifying the values of the patient (P), estimates (1408) by means of the nonlinear classifier a respective class of risk (v) for each modified dataset (304), and adds the values of each modified dataset (304) and the respective estimated class of risk (v) to the training dataset (306). Next, the computer determines a class of risk (v) from among the estimated classes of risk (v) that indicates a lower risk and trains (1112) a linear classifier configured to estimate the class of risk (v) as a function of the values of the clinical data (p) using the training dataset (306). The computer then determines a separation plane (402) of the linear classifier that separates the class of risk (v) estimated for the patient (P) from the class of risk (v) that indicates a lower risk, and uses the separation plane (402) to calculate the minimum modification required (MP) to the values of the patient (P) to modify the estimated class of risk (v) into the class of risk (v) that indicates a lower risk. Finally, the computer can provide support to clinical decisions by displaying the modification (MP) to the values of the patient (P) on a screen.
Patent CA-3207505-A1 (CA)
Title: Building components, structures formed thereform and related methods
Inventor: KELLER CASEY S
IPC: E04F11/104
Filed: 2023-07-21
Abstract: Building materials described herein include a structure having a substrate and a coating fomied on the substrate. In one embodiment, the coating may include a mixture or rubber in urethane. For example, in one embodiment, mixture may include approximately 8%  to approximately 12% by weight of urethane, approximately 2% to approximately 5%  by weight of water, and approximately 81% to approximately 90% by weight of rubber. In some embodiments, the mixture may include a colorant, a fire retardant, and/or an ultraviolet (UV) inhibitor.
Patent CA-3213792-A1 (CA)
Inventor: THON JONATHAN
IPC: A61K35/19
Filed: 2022-04-26
Abstract: Des compositions et des procédés associés à des vésicules extracellulaires dérivées de mégacaryocytes dérivées de cellules souches pluripotentes humaines sont divulgués, les vésicules extracellulaires dérivées de mégacaryocytes pouvant être utilisées pour traiter l'anémie de Fanconi (AF).
Patent CA-3214179-A1 (CA)
Inventor: DEUTSCH SAMUEL
IPC: A61P31/14
Filed: 2022-04-01
Abstract: La divulgation concerne des substances sous la forme de nanoparticules contenant des ARNm transcrits in vitro codant pour des peptides antigéniques et des méthodes de médecine personnalisée de traitement ou de prévention de maladies telles que le cancer, une maladie auto-immune, une maladie infectieuse, ou une inflammation, les cellules d'un sujet recevant un traitement prophylactique ou thérapeutique étant mises en contact avec les nanoparticules ex vivo, et les cellules du sujet traitant l'ARNm, exprimant et présentant le produit codé pour activer les propres lymphocytes T du sujet, ce qui permet de provoquer une réponse immunitaire chez les cellules malades, telles que les cellules cancéreuses.
Patent CA-3214202-A1 (CA)
Inventor: ISSAFRAS HASSAN
IPC: C07K16/30
Filed: 2022-04-22
Abstract: L'invention concerne des anticorps et des dérivés d'anticorps qui se lient à GPC3 et des procédés d'utilisation de ceux-ci. L'anticorps ou le dérivé d'anticorps comprend un anticorps à domaine unique qui se lie à GPC3.
Patent CA-3215455-A1 (CA)
Title: Detection d'alignement de remorque pour automatisation d'amarrage a l'aide d'un systeme de vision et d'un filtrage de profondeur dynamique
Inventor: PENALOZA JIMMY ERIK
IPC: G06T7/73
Filed: 2022-04-13
Abstract: L'invention concerne des systèmes et des procédés pour déterminer un alignement d'une remorque par rapport à une baie d'amarrage ou à une porte de baie de véhicule à l'aide d'un filtrage de profondeur dynamique. Des données d'image et des données de position sont capturées par un système de caméra 3D avec un champ de vision orienté au moins partiellement vers le bas. Lorsqu'une remorque se rapproche de la baie ou de la porte d'amarrage, les données d'image capturées comprennent une surface supérieure de la remorque. Une plage de hauteur dynamique est déterminée sur la base d'une hauteur estimée de la surface supérieure de la remorque dans les données d'image et un filtre de profondeur dynamique est appliqué pour filtrer des données d'image correspondant à des hauteurs à l'extérieur de la plage de hauteur dynamique. Une position angulaire et/ou un décalage latéral de la remorque sont déterminés sur la base des données d'image filtrées en profondeur.
Patent CA-3219500-A1 (CA)
Inventor: HENDERSON THEODORE
IPC: A61K31/522
Filed: 2021-05-28
Abstract: The disclosure relates to methods for treating a virally induced functional disorder (VIFD), a functional somatic syndrome (FSS) and/or a herpes-family virus by administering a therapeutically-effective combination of an antiviral compound and nitazoxanide. The disclosure is further related to pharmaceutical compositions comprising a combination of an antiviral compound and nitazoxanide.
Patent CA-3220945-A1 (CA)
Inventor: YOAKIM ALFRED
IPC: A47J31/44
Filed: 2022-07-11
Abstract: A container (6) arranged for containing a precursor material for use with a machine (4) for preparing a beverage and/or foodstuff, the container comprising: a storage portion (58), a closing member (56), a flange (60) connecting the storage portion and closing member, a machine-readable code (44) storing preparation information for use with a preparation process performed by said machine, and a code carrying member (62), wherein the flange comprises a viewing window (84), the code carrying member (62) extending over the viewing window (84) at a side of the flange that comprises an upper surface (68) of the flange (60), and the code (44) arranged on a flange facing surface (64) of the code carrying member (62), wherein the code (44) is readable from a side of the flange (60) that comprises a lower surface (70) of the flange through the viewing window (84).
Patent WO-9215713-A1 (WO)
Title: Procede de recuperation de metal
Inventor: O'BRIEN ROBERT N
IPC: C25C1/14
Filed: 1992-03-05
Abstract: On décrit un procédé de récupération d'un métal à partir d'une charge d'alimentation comprenant un métal choisi à partir du groupe composé d'or, de platine, d'argent, de cuivre, de nickel, de zinc, de plomb, d'antimoine, de molybdène, de chrome, de mercure, de manganèse, d'étain, d'autres éléments, de la série de platine et de combinaisons de ces métaux. Le procédé consiste à: (a) mettre la charge en contact avec un mélange aqueux composé de nitrate d'ammonium en une concentration supérieure à 1,5 M environ, et d'acide sulfurique en une concentration supérieure à 6 M environ et à une température d'au mois 105 °C environ, afin de produire un résidu insoluble et un produit de lessivage contenant le métal dissous; (b) séparer le résidu du produit de lessivage; et (c) récupérer le métal du produit de lessivage. Le procédé présente en particulier des avantages en ce qui concerne la récupération d'or et d'autres métaux précieux, tout en pouvant être utilisé pour la récupération du cuivre.
Patent WO-9220790-A1 (WO)
Title: Transgenic non-human animal carrying a non-infectious hiv genome
Inventor: JOLICOEUR PAUL
IPC: A01K67/027
Filed: 1992-05-14
Abstract: Disclosed herein is a transgenic non-human animal carrying a transgene which expresses non-infectious HIV ribonucleic acid and complementary proteins thereof. Among the expressed proteins, which can be found in the milk, serum and several tissues, are the gag and envelope proteins. The transgenic animal is useful as a source for obtaining the complementary proteins, and as an animal model to study HIV host cell interactions and to evalulate anti-HIV drugs.